BioCentury | Feb 28, 2020
Distillery Therapeutics

Sodium nitrite plus EDTA for bacterial infections

DISEASE CATEGORY: Infectious disease INDICATION: Pseudomonas; Gram-positive bacterial infection; Gram-negative bacterial infection Arch Biopartners’ AB569, a combination of sodium nitrite and ethylenediaminetetraacetic acid (EDTA), could treat infections by Pseudomonas aeruginosa and other bacteria. The two...
BC Week In Review | Apr 4, 2016
Company News

University of Cincinnati, Arch Biopartners deal

Arch exercised an option to exclusively license AB569 from the university. The university will receive an undisclosed upfront payment and is eligible for milestone payments. Arch expects to begin clinical trials by early 2017. The...
Items per page:
1 - 2 of 2